A Study of DSP-0509 in Patients With Advanced Solid Tumors to Determine the Safety and the Pharmacokinetic Profile
Clinical trial NCT03416335 · TERMINATED
Trial details
- NCT number
- NCT03416335
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-01
- Primary completion
- 2022-12-20
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.